Kewaunee Scientific Corporation (KEQU)

Kewaunee Scientific Income Statement

Financials in millions USD. Fiscal year is May - April.

Year	2024	2023	2022	2021	2020
Revenue	203.76	219.49	168.87	147.47	147.54
Revenue Growth (YoY)	-7.17%	29.98%	14.51%	-0.05%	0.68%
Cost of Revenue	151.7	183.91	144.65	123.48	124.11
Gross Profit	52.05	35.59	24.22	23.99	23.43
Selling, General & Admin	33.77	30.22	26.83	25.31	25.77
Other Operating Expenses	4.18	0.07	-0.36	1.15	0.45
Operating Expenses	37.95	30.3	26.47	26.46	26.23
Operating Income	14.1	5.29	-2.25	-2.47	-2.8
Interest Expense / Income	1.8	1.73	0.63	0.39	0.49
Other Expense / Income	-0.51	-0.32	-0.28	-0.18	-0.36
Pretax Income	12.82	3.88	-2.61	-2.68	-2.93
Income Tax	-5.94	3.14	3.52	0.99	1.76
Net Income	18.75	0.74	-6.13	-3.67	-4.69
Net Income Growth	2441.06%	-	-	-	-
Shares Outstanding (Basic)	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3
Shares Change	1.24%	4.16%	0.94%	0.36%	-1.57%
EPS (Basic)	6.51	0.26	-2.20	-1.33	-1.70
EPS (Diluted)	6.38	0.25	-2.20	-1.33	-1.70
EPS Growth	2452.00%	-	-	-	-
Free Cash Flow	15.19	-7.94	-9.79	-1.49	1.7
Free Cash Flow Per Share	5.28	-2.81	-3.52	-0.54	0.62
Dividend Per Share	-	-	-	-	0.380
Dividend Growth	-	-	-	-	-48.65%
Gross Margin	25.55%	16.21%	14.34%	16.27%	15.88%
Operating Margin	6.92%	2.41%	-1.33%	-1.67%	-1.90%
Profit Margin	9.20%	0.34%	-3.63%	-2.49%	-3.18%
Free Cash Flow Margin	7.46%	-3.62%	-5.80%	-1.01%	1.15%
Effective Tax Rate	-46.34%	80.96%	-	-	-
EBITDA	17.74	8.48	0.79	0.39	0.22
EBITDA Margin	8.71%	3.86%	0.47%	0.27%	0.15%
Depreciation & Amortization	3.13	2.87	2.77	2.69	2.65
EBIT	14.61	5.61	-1.98	-2.29	-2.44
EBIT Margin	7.17%	2.56%	-1.17%	-1.55%	-1.65%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).